Cost-Effectiveness for Surgical Treatment of Degenerative Spondylolisthesis

Kristen E Jones; David W Polly Jr

doi:10.1016/j.nec.2019.02.010

Cost-Effectiveness for Surgical Treatment of Degenerative Spondylolisthesis

Neurosurg Clin N Am. 2019 Jul;30(3):365-372. doi: 10.1016/j.nec.2019.02.010. Epub 2019 Apr 10.

Authors

Kristen E Jones¹, David W Polly Jr²

Affiliations

¹ Department of Neurosurgery, University of Minnesota, Minneapolis, MN, USA. Electronic address: [email protected].
² Department of Neurosurgery, University of Minnesota, Minneapolis, MN, USA; Department of Orthopaedic Surgery, University of Minnesota, 2450 Riverside Avenue Southeast, Suite R200, Minneapolis, MN 55454, USA.

PMID: 31078237
DOI: 10.1016/j.nec.2019.02.010

Abstract

Surgery for degenerative lumbar spondylolisthesis is significantly more cost-effective than nonsurgical management in patients who have failed to improve with a 6-week trial of nonsurgical management. Decompression plus fusion becomes more cost-effective compared with decompression alone at 2 years following surgery. Further study is needed to evaluate the most cost-effective fusion approach and augmentation strategy.

Keywords: Cost-effectiveness analysis; Degenerative spondylolisthesis; ICER; QALY.

Publication types

Review

MeSH terms

Cost-Benefit Analysis*
Decompression, Surgical / economics*
Humans
Lumbar Vertebrae / surgery
Spinal Fusion / economics
Spinal Stenosis / economics*
Spinal Stenosis / surgery
Spondylolisthesis / surgery*